ARTBIO
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines. ARTBIO is changing cancer care by creating a new class of alpha radioligand therapeutics (ART) and the ecosystem that supports.
ARTBIO
Industry:
Biotechnology Health Care Hospital Medical Medical Device Pharmaceutical
Founded:
2021-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.artbio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
113 M USD
Technology used in webpage:
Amazon Equinix
Similar Organizations
Acorai
Acorai is a medical device manufacturer of non-invasive intracardiac pressure monitoring to improve heart failure management.
Asepha
AI clinical tools to enable automation and personalization in pharmacies.
EmployerDirect Healthcare
EmployerDirect Healthcare is a supplemental healthcare benefit that directs planned medical procedures to high-quality providers.
HCA
Hospital Corporation of America (HCA) provides healthcare services in locally managed facilities in 20 states in the U.S. and England.
HealNow
HealNow is the online payments and on-boarding platform for pharmacies.
Pomelo Care
Pomelo Care develops an online pregnancy care platform to provide virtual maternity and neonatal care services.
TriNetX
TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Omega Funds
Omega Funds investment in Series A - ARTBIO
Third Rock Ventures
Third Rock Ventures investment in Series A - ARTBIO
F-Prime Capital
F-Prime Capital investment in Series A - ARTBIO
F-Prime Capital
F-Prime Capital investment in Seed Round - ARTBIO
Omega Funds
Omega Funds investment in Seed Round - ARTBIO
Key Employee Changes
| Date | New article |
|---|---|
| 2023-10-05 | ARTBIO Announces Appointment of Nick Pullen, Ph.D., as Chief Scientific Officer |
Official Site Inspections
http://www.artbio.com Semrush global rank: 9.93 M Semrush visits lastest month: 288
- Host name: afa7f374f51cc8991.awsglobalaccelerator.com
- IP address: 3.33.186.135
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "ARTBIO"
ARTBIO - Crunchbase Company Profile & Funding
Organization. ARTBIO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... ARTBIO is a …See details»
ARTBIO - LinkedIn
ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a ...See details»
Artbio Company Profile - Office Locations, Competitors, Revenue …
Artbio has 5 employees across 4 locations and $90 m in total funding,. See insights on Artbio including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
ARTBIO 2025 Company Profile: Valuation, Funding
ARTBIO General Information Description. Operator of a radiopharmaceutical company intended to offer a new approach to the treatment of cancer. The …See details»
ARTBIO - Contacts, Employees, Board Members, Advisors
Organization. ARTBIO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Advisor Profiles 3. Contacts 18. About. ARTBIO has 4 …See details»
ARTBIO - Work in biotech
ARTBIO is a clinical-stage radiopharmaceutical company that develops new alpha radioligand therapies (ARTs). ARTBIO's approach uses tumor-specific targets and the best alpha …See details»
ArtBio Inc. - Life-Sciences-Europe.com
Jan 1, 2021 The unique ARTBIO approach selects the optimal alpha-precursor isotope (Pb-212) and tumor-specific targets to create therapeutics with the potential for highest efficacy and …See details»
ARTBIO - VentureRadar
ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. Radioligand therapy (RLT) has …See details»
ARTBIO
ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. The ARTBIO Approach: Patients at …See details»
Our Approach - ARTBIO
U.S. (Headquarters) ARTBIO Inc. c/o Alexandria LaunchLabs One Kendall Sq, B200, Suite 001 Cambridge, MA 02139 Switzerland ARTBIO GmbH Aeschengraben 9 4051 Basel, Switzerland Norway ARTBIO AS Kjelsåsveien …See details»
ARTBIO - Leadership Team - The Org
The Leadership Team at ARTBIO is responsible for steering the company’s strategic vision and operational execution. This team, comprised of key executives including the CEO, Vice …See details»
ARTBIO - Funding, Financials, Valuation & Investors - Crunchbase
Jun 21, 2023 ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines. ... Experience the new …See details»
ArtBio GmbH - Swiss Biotech
ARTBIO is a clinical-stage radiopharmaceutical company focused on developing a new class of alpha radioligand therapies (ARTs) to transform cancer treatment. ARTBIO's approach centers …See details»
Mission, Vision & Core Values of ARTBIO – …
Dec 19, 2024 ARTBIO’s mission, vision, and core values play a critical role in shaping the success of the company in the competitive biotechnology industry. By defining the purpose …See details»
ARTBIO - The Hub
ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is …See details»
ARTBIO Raises Oversubscribed and Upsized $90 Million Series A …
Dec 7, 2023 Ä6 F$íÅ QQûa³ œ´zÔ‘ºðçÏ¿ Žë±ÎûôUë¿~ Î °ß‘\vQÒy_²Ý—º¥ã`P -ÑQ[ — šp‹Èªý¹–¹ GmÁ£ˆè|®õßç“Du|ëÌU¬* ”»x ÁVl ZÁ¶õ/See details»
ARTBIO Launches to Develop New Class of Alpha Radioligand …
Jun 21, 2023 ARTBIO was founded in 2021 by Roy Larsen, Øyvind Bruland, Radforsk, and F-Prime Capital to create highly targeted cancer therapies by pairing the optimal alpha-emitting …See details»
ARTBIO - Updates, News, Events, Signals & Triggers - Crunchbase
Organization. ARTBIO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Growth Insight Details. Powered by AI . ... ARTBIO has …See details»
Landmark Bio Acquired by Artis BioSolutions to Expand …
3 days ago The organization was established by leaders from academia, industry, and Boston's leading research hospitals. Together with Artis BioSolutions, Landmark Bio will enhance its …See details»
ARTBIO Launches to Develop New Class of Alpha Radioligand …
Jun 21, 2023 `¿€ØgÓ÷tÕ ÒV¸t œ^ï ƒ 0zrÓpý~ŠUˆ šWÞûß ÷ÆÌžzÅÝ âÝ‘ÄbbˆDbcÐQÍÚÞSt|!@*³ pöB íË ²É~£pöó ?"ÊF ˆó$ðAn“ ¾Ü0÷’ŽÁœò"See details»